Alphatec Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
Hello, everyone. Thanks for joining us for another session today. I'm Drew Ranieri. I'm the medical device analyst here at Morgan Stanley, and it's my pleasure today to have Alphatec with us, CEO, Pat Miles; and CFO, Todd Koning.
So before we jump into it, just a quick disclaimer, but important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your MS sales rep.
With that out of the way, thanks again for being here, Pat and Todd.
Questions & Answers
And maybe Pat, for you to start before we get into some of the growth drivers. I think we need some help at least from what I can see, you're continuing to take share, you're driving the highest growth in spine, you're on the cusp of -- well, you have turned EBITDA profitable, yet investors look at the chart and see the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
